Related by context. All words. (Click for frequent words.) 55 Sustained Virologic Response 54 achieved sustained virological 53 Sustained virological response 52 Standard Variable Rate 52 Sustained Virological Response 51 achieve sustained virological 51 sustained virologic response 50 Sluzhba 50 SVRs 47 achieved sustained virologic 47 sustained virological response 45 RGT arm 45 achieve sustained virologic 45 Syniverse Technologies NYSE 45 HCV genotype 45 pegylated interferon 45 Base Rate 45 Sustained virologic response 44 tracker mortgages 44 telaprevir dosed 44 Syniverse Holdings 43 FSB 43 peginterferon alfa 2b 42 CML 42 topotecan 42 undetectable HCV RNA 42 Variable Rates 42 achieving sustained virologic 41 proc fees 41 HCV genotype 1 41 plus dexamethasone 41 gemcitabine carboplatin 41 SVR# 41 proc fee 41 Skipton Building Society 41 plus COPEGUS 40 peginterferon 40 Skipton BS 40 virologic response 40 INNOVATOR 40 relapsed refractory multiple myeloma 40 Syniverse Technologies SVR 40 XELOX 40 surgical ventricular 40 LTVs 40 Velcade 40 FlexAccount 40 0pc 40 Free Survival PFS 40 Skripal 39 comparator PI r 39 chlorambucil 39 undetectable viral load 39 null responders 39 GRU 39 lamivudine monotherapy 39 viral loads 39 Moneyback Bank 39 infliximab 39 evaluable patients 39 KGB 39 free survival PFS 39 lenalidomide 39 CR CRu 39 remortgagers 39 bortezomib 39 Godiva Mortgages 39 ACR# response 39 procuration fees 39 rituximab 39 mRCC 39 Aptivus ® 39 Alexander Poteyev 39 log# IU mL 39 tenecteplase 38 REYATAZ r 38 ritonavir boosted 38 pCR 38 remission CR 38 HCV 38 anti TNF 38 MegaFon 38 Oleg Gordievsky 38 Complete Response CR 38 imatinib 38 neutrophil count 38 HCV infected 38 Poteyev 38 marketed EGFR 38 sunitinib 38 Edeus 38 remortgage 38 ribavirin RBV 38 tumor shrinkage 38 candesartan 38 Median PFS 38 losartan 38 viral load 38 FAPSI 38 CreditExpert 38 telaprevir 38 HCV RNA 38 prior relapsers 38 trastuzumab 38 seroconversion 37 ofatumumab 37 5FU 37 TMC# [001] 37 tipranavir 37 carboplatin 37 mg kg dose 37 ABC/3TC 37 lapatinib 37 chronic hepatitis C 37 metastatic colorectal cancer 37 vertebral fracture 37 IPStream 37 CR nPR 37 tirofiban 37 lamivudine 37 spokesman Boris Labusov 37 lender SVR 37 #mg QD [002] 37 cytogenetic response 37 Kaplan Meier analysis 37 Hazard Ratio 37 follicular NHL 37 interferon ribavirin 37 metastatic renal cell carcinoma 37 Aldrich Ames 37 M#V mutation 37 Yevroset 37 primary endpoint 37 low introductory teaser 37 Stolen Vehicle Recovery 37 peginterferon alfa 2a 37 complete cytogenetic 37 John Charcol 37 mcg albinterferon alfa 2b 37 homeloan 37 Experian 37 Ingosstrakh 36 HBoS 36 platelet reactivity 36 mform.co.uk 36 Isa Saver 36 TAXUS stent 36 oral diclofenac 36 boceprevir 36 relapsed refractory 36 median PFS 36 rituximab refractory 36 self cert 36 Aldermore 36 copies ml 36 copies mL 36 chronic HCV genotype 36 radiographic progression 36 HomeServe 36 Gennady Vasilenko 36 nilotinib 36 annualized relapse 36 CCR5 tropic HIV 36 plus ribavirin 36 log# copies mL 36 refractory NSCLC 36 Accord Mortgages 36 temozolomide 36 dasatinib Sprycel 36 remortgaging 36 plasma renin activity 36 Karen Wint 36 Spicerhaart Financial 36 prior chemotherapy regimens 36 HBV DNA 36 neoadjuvant chemotherapy 36 sorafenib 36 HbA1c 36 LTV 36 HCV SPRINT 36 Comstar 36 PegIFN RBV 36 irbesartan 36 DAS# remission 36 docetaxel chemotherapy 36 Russky Standart 36 mitoxantrone 36 CRp 36 relapsers 36 virologic failure 36 businessman Andrei Lugovoi 36 rapid virologic response 36 AVADO 36 naive HCV 36 CIMZIA TM 36 Poltoranin 36 Rituxan 36 gefitinib 36 alemtuzumab 36 Eurotel 36 BT IPStream 36 IIIa inhibitors 36 HCV RESPOND 2 36 Procoralan 36 detectable HCV RNA 36 FOLFIRI 36 log# 36 Year Fixed Rate 36 RusRating 36 Haart estate 36 anthracycline 36 placebo dexamethasone 36 nonresponders 36 GMAC RFC 36 Lt. Col. Pavel Ryaguzov 36 myelodysplastic syndromes MDS 36 Pavel Ryaguzov 36 clodronate 36 ZD# [001] 36 FRMs 36 Siloviki 36 goserelin 36 imetelstat 36 GIST 35 HBeAg seroconversion 35 Fludara 35 Regular Saver 35 BT TalkTalk 35 MACCE 35 #mg QD [001] 35 ILLUMINATE 35 recurrent GBM 35 CPOP R 35 imatinib Gleevec 35 disease progression 35 degarelix 35 Kim Philby 35 plus MTX 35 Permanent TSB 35 CD# + [002] 35 antiangiogenic therapy 35 adefovir 35 IPSS 35 Birmingham Midshires 35 genotype 1b 35 BCR ABL mutation 35 plasma HCV RNA 35 TNX 35 pegylated interferon peg IFN 35 stage IIIB 35 peg IFN 35 Xeloda 35 ivabradine 35 carboplatin paclitaxel 35 United TeleSystems JSC 35 chemotherapeutic regimen 35 naïve HCV 35 remortgages 35 virological suppression 35 zalutumumab 35 IRLS score 35 serum PSA 35 mutated KRAS 35 viral kinetics 35 coinfected 35 T#I [002] 35 interferon 35 acronym FSB 35 Francis Ghiloni 35 NMIBC 35 IFN α 35 olaparib 35 Lupuzor ™ 35 lumiliximab 35 Charcol 35 rhEPO 35 KRAS status 35 liver metastases 35 PLR 35 Vanquis 35 Mobile TeleSystems 35 atazanavir ritonavir 35 Partial Response 35 CCL# 35 lopinavir r 35 azacytidine 35 lymphocytosis 35 sirolimus eluting stent 35 Lloyds TSB 35 zoledronic acid 35 ISEL 35 ribavirin 35 glycated hemoglobin levels 35 chronic HCV 35 SCDEA 35 Pemetrexed 35 Imatinib 35 CCyR 35 Westport Wiscasset 35 EGFR expressing 35 LEXIVA r 35 Colonel Shcherbakov 35 pegIFN 35 Robert Hanssen 35 serum testosterone 35 periprocedural 35 anastrozole 35 TalkTalk 35 SUVmax 35 IU ml 35 Shcherbakov 35 serum HCV RNA 35 biochemical recurrence 35 metastatic CRC 35 Euroset 35 achieved ACR# 35 Regular Saver account 35 extradite Lugovoy 35 q8h 35 rituximab monotherapy 35 etoposide 35 baseline HbA1c 35 dacarbazine 35 CsA 35 lopinavir 35 oral allopurinol 34 imatinib therapy 34 patency 34 progression TTP 34 VTB# 34 CIMZIA ™ 34 eplerenone 34 edeus 34 PegIFN 34 Kensington Mortgages 34 dose dexamethasone 34 ug dose 34 TVR 34 Lenalidomide 34 ribavirin therapy 34 Zaporozhsky 34 ULORIC 34 previously untreated follicular 34 follicular lymphomas 34 leukocyte count 34 allopurinol 34 CD4 + cells 34 Britannia Building 34 recurrent NSCLC 34 estrogen receptor progesterone receptor 34 enalapril 34 auto allo 34 MabCampath 34 interferon alfa 2a 34 Andrey Lugovoy 34 NNRTI 34 Circulating tumor cells 34 AllofMP3 34 VELCADE melphalan 34 angiographic restenosis 34 sUA 34 FOLFOX4 34 borrowers 34 cobicistat 34 Cifas 34 Rate Libor 34 CRu 34 Fone Logistics 34 unresectable stage 34 TAXUS Stent 34 evaluable 34 tipranavir ritonavir 34 log# reduction 34 Amrubicin 34 APTIVUS R 34 HIV RNA 34 protease inhibitor 34 Oleg Penkovsky 34 Oncophage 34 IFN alfa 34 perindopril 34 Halyk Bank 34 Tretyakov 34 Risk premia 34 5 FU 34 #mg BID [001] 34 glycated hemoglobin HbA1c 34 leukocytes 34 liver histology 34 Uniastrum 34 experienced virologic failure 34 darunavir ritonavir 34 G CSF 34 fludarabine 34 lymphoma CTCL 34 neurologic progression 34 randomized #:# 34 chemoradiotherapy 34 cyclophosphamide FC 34 DMARD 34 gross pa AER 34 MICARDIS ® 34 SMERSH 34 neutrophil counts 34 TAXUS 34 Boceprevir 34 circulating EPCs 34 NSCLC 34 bezafibrate 34 TRITON TIMI 34 PSA nadir 34 pegfilgrastim 34 imatinib mesylate Gleevec 34 hepatitis C genotype 34 BMS # 34 olmesartan 34 azacitidine 34 gefitinib Iressa 34 APR 34 vandetanib 34 lenders SVRs 34 TMEM density 34 HIBOR 34 fluvastatin 34 plasma concentrations 34 Median survival 34 del 5q 34 chemotherapy regimens 34 glomerular filtration 34 elvitegravir 34 Comstar UTS 34 Mitrokhin 34 indapamide 34 cisplatin 34 virological failure 34 Peg IFN 34 cashback 34 Vadim Zaitsev 34 URSA Bank 34 gastrointestinal stromal tumors 34 Gleevec resistant 34 MELD scores 34 insulin glargine 34 Mform.co.uk 34 Sigurnost 34 Comstar Direct 34 temsirolimus 34 HER2 negative 34 counterspies 34 achieved CCyR 34 HbA1C 34 undetectable virus HCV 34 Sinowal 34 KRAS wild 34 dose melphalan 34 extradite Andrei Lugovoy 34 FluCAM 34 mapatumumab 34 re mortgaging 34 Oleg Morozov 34 complete remissions 34 fulvestrant 34 RateCity 34 QTcF 34 rate mortgages ARMs 34 ipilimumab 34 tyrosine kinase inhibitor TKI 34 autologous stem cell 34 alkylating agents 34 mg BID 34 immunosuppressant 34 plus methotrexate 34 Topol M 34 axitinib 33 peginterferon alfa 2a #KD 33 Kremlin 33 mCRC 33 viral suppression 33 roaming tariffs 33 erlotinib 33 Telaprevir 33 nitazoxanide 33 FOLFOX 33 AfI 33 dutasteride 33 untreated CLL 33 perifosine 33 μmol L 33 HBeAg positive 33 Aleksandr Litvinenko 33 EDSS scores 33 Homeserve 33 RBS Natwest 33 biochemical relapse 33 chemoresistant 33 amlodipine 33 seliciclib 33 HBsAg 33 decitabine 33 leukemic cells 33 Shabalkin 33 bendamustine 33 Vneshtorgbank VTB 33 mg ustekinumab 33 complete cytogenetic response 33 Kurtsin 33 Median progression 33 Rosbank 33 follicular lymphoma 33 B CLL 33 histologies 33 Spicerhaart 33 Evgeny Primakov 33 target lesion revascularization 33 LMWH 33 sorafenib Nexavar 33 DMARDs 33 defibrotide 33 reintervention 33 Viktor Ivanov 33 recurrent GBM patients 33 Gudkov 33 pegylated interferon alfa 33 IRESSA 33 Alexander Andreyechkin 33 PCa 33 cystectomy 33 OPTIMIZE 33 monthly repayments 33 docetaxel Taxotere ® 33 COPAXONE ® 33 taxane chemotherapy 33 undetectable viral loads 33 CLL 33 Andrei Lugovoi 33 advanced NSCLC 33 ERBB2 33 Target Lesion Revascularization TLR 33 moneyfacts.co.uk 33 dasatinib 33 cediranib 33 FDA defined valvulopathy 33 angiotensin converting enzyme ACE 33 p = #.# [004] 33 target lesion revascularizations 33 locoregional recurrence 33 XIENCE V PROMUS Stent 33 #.#Mbps [002] 33 Equifax 33 FIRMAGON 33 EGFR expressing mCRC 33 neoadjuvant 33 daunorubicin 33 serum ALT 33 virological response 33 HomePhone 33 Pichugin 33 5 HT2B receptor 33 relapsed SCLC 33 survivin 33 Provident Financial 33 angiotensin converting enzyme inhibitor 33 RECIST criteria 33 #Mbits/sec [002] 33 raltegravir 33 interferon beta 33 refi rate 33 Cetuximab 33 oxaliplatin 33 CD4 cell 33 relapsed Hodgkin lymphoma 33 coinfected patients 33 Ceplene 33 placebo 33 PEG interferon 33 ramipril 33 seropositive patients 33 binary restenosis 33 below SBAR 33 antidiabetic 33 pegylated interferon ribavirin 33 rates 33 disease progression TTP 33 relapsed ovarian cancer 33 Cancer AACR NCI 33 Megafon 33 CTLs 33 Tele2 33 Andrei Lugovoy 33 Rosgosstrakh 33 #mg BID [002] 33 Soldatenkov 33 PLX# 33 AMN# [001] 33 gemcitabine 33 neoadjuvant therapy 33 TNF inhibitors 33 reconviction 33 JSC Sitronics 33 Mortgageforce 33 OAO Vimpel Communications 33 Anelik 33 defector accuses 33 HLA DR2 33 PEG IFN 33 Pixuvri 33 extradite Andrei Lugovoi 33 Viktor Pleshchuk 33 Valentyn Nalyvaychenko 33 Vanquis Bank 33 talabostat 33 endoscopic remission 33 Dmitry Rogozin 33 ponatinib 33 abiraterone acetate 33 Adjustable Rate Mortgages 33 atazanavir 33 DOXIL ® 33 CYPHER ® Stent 33 Elitek 33 EGFR mutation positive 33 seroprotection 33 Copegus ribavirin 33 CYP#A# substrate 33 VICTRELIS 33 Peginterferon Alfa 2a 33 Lugovoy extradition 33 Uralsib 33 belimumab 33 PhonepayPlus 33 doxorubicin 33 Telcyta 33 tyrosine kinase inhibitor 33 Kaupthing Edge 33 A1c levels 33 FSB Nikolai Patrushev 33 CD8 + lymphocytes 33 IL#B 33 heavily pretreated 33 TNF inhibitor 33 codenamed Stakeknife 33 severe neutropenia 33 ACR# responses 33 alfa 2a 33 rizatriptan 33 boosted atazanavir 33 hepatitis C HCV 33 Flu Cy 33 sUA levels 33 HBOS 33 Fludarabine 33 goalkeeper Igor Akinfeev 33 peg interferon 33 Telewest 33 Temirbank 33 Fixed Rate ISA 33 entecavir 33 Sergei Gaidukevich 33 ASA# 33 abacavir lamivudine 33 adalimumab Humira 33 Alfa 33 Remortgage 33 p = #.# [002] 33 pazopanib 33 REMICADE monotherapy 33 ximelagatran 33 5-FU/LV 33 MI5 MI6 33 diameter stenosis 33 platelet counts 33 Cahoot 33 CD4 + CD# 33 Incepta 33 prostate cancer CRPC 33 A1Cs 33 VTB VTBR.MM 33 ZACTIMA 33 relapsed MM 33 NatWest 33 8Mb 33 Pegasys plus Copegus 33 interferon therapy 33 Protelos 33 refractory systemic ALCL 33 serum urate 33 dose interleukin 33 -#.# log# 33 RPS1 33 Instant Saver 33 achieving PASI 33 Kaplan Meier estimates 33 Vympelcom 33 prospectively defined 32 operator VimpelCom 32 occult metastases 32 Moscow Narodny Bank 32 taxane therapy 32 imipenem 32 virologic suppression 32 infliximab monotherapy 32 adriamycin 32 Taxotere ® 32 VFEND 32 KGB successor 32 Kivexa 32 Revlimid 32 Alexander Morozov 32 piperacillin tazobactam 32 unfractionated heparin 32 siloviki 32 Tykerb 32 dose cytarabine 32 ACTEMRA TM 32 CD4 + 32 adecatumumab 32 former KGB colonel 32 MI5 32 gemcitabine Gemzar 32 RIPA 32 NRTI 32 CLL SLL 32 metastatic hormone refractory 32 low dose dexamethasone 32 YERVOY 32 Hb levels 32 plasma uric acid 32 interest rates 32 docetaxel 32 Xcytrin 32 EBMT criteria 32 rogue dialers 32 Omacetaxine 32 BTL 32 Solid Tumors criteria 32 Kvachkov 32 metastatic malignant melanoma 32 Torisel 32 Zharko 32 HER2 + 32 COPAXONE 32 operable pancreatic cancer 32 KGB defector 32 Pixantrone 32 cytotoxic agents 32 chemotherapy docetaxel 32 imiquimod 32 virologic 32 origination fee 32 BCG refractory 32 gross AER 32 tofacitinib 32 LPV r 32 oblimersen 32 Mehrdad Yousefi 32 trabedersen 32 p = 32 ACR# [002] 32 tipranavir r 32 ServicePower Technologies 32 Pegylated Liposomal Doxorubicin 32 platelet inhibitor 32 MTS VimpelCom 32 BAY #-# 32 pomalidomide 32 Rasilez Tekturna 32 Fixed Rate Mortgage 32 galiximab 32 +2 bp 32 IIIa inhibitor 32 PegIntron 32 Grishankov 32 Atacand 32 stage IIIA 32 Creditsafe 32 mTOR mammalian target 32 cytostatic 32 undetectable PSA 32 STELARA 32 levosimendan 32 AToM 32 infliximab therapy 32 refractory follicular lymphoma 32 stage IIIb IV 32 HAMP modifications 32 randomized #:#:# 32 Venona 32 nodular partial response 32 ex KGB 32 adalimumab 32 Rietumu Banka 32 MosPrime 32 HbA1c levels 32 ZOMIG Nasal Spray 32 FOLFOX6 32 bosentan 32 valsartan 32 allogeneic SCT 32 Catapult DCT# ® 32 EGFR TKI 32 CDAI 32 Gordievsky 32 prior antiangiogenic therapy 32 nab paclitaxel 32 KGB spy 32 reperfusion 32 HCFB 32 Alexander Zaporozhsky 32 pixantrone 32 TDF FTC 32 MVax R 32 relapsed CLL 32 adverse cytogenetics 32 HAM D# scores 32 uswitch.com 32 enoxaparin 32 untreated multiple myeloma 32 rate 32 send intels intelligence 32 REYATAZ R 32 unauthorized overdraft fees 32 libor 32 radical prostatectomy RP 32 mg Lucentis 32 evaluable subjects 32 treatment naive genotype 32 Valentin Velichko 32 lamivudine refractory patients 32 sCD# 32 Kaplan Meier estimate 32 imatinib mesylate 32 Annual Percentage 32 anacetrapib 32 Gemcitabine 32 serum HBV DNA 32 capecitabine 32 asymptomatic carotid stenosis 32 FTY# 32 asymptomatic metastatic 32 secondary endpoint 32 Skipton 32 bicalutamide 32 radical cystectomy 32 BT Cellnet 32 patients evaluable 32 subcutaneously administered 32 octreotide 32 bp 32 K ras mutations 32 CK # plasma concentrations 32 bortezomib Velcade R 32 tumor regressions 32 Kaspersky 32 Hb A1C 32 ANCHOR trial 32 dose cohorts 32 Topotecan 32 RPLR 32 telbivudine 32 genotype 32 metastatic HRPC 32 EGFR mutation 32 glargine 32 COMBIVIR 32 monotherapy 32 iodixanol 32 State Duma 32 dose GATTEX 32 OGPU 32 diagnosed multiple myeloma 32 atorvastatin #mg 32 pegylated interferon alfa 2a 32 Diffuse Large B 32 Waldenstrom Macroglobulinemia 32 Boris Abramovich 32 interferon beta therapy 32 OAO Mobile TeleSystems 32 CZP 32 Sorafenib 32 methotrexate MTX 32 amrubicin 32 Pegasys ® 32 sleeve lobectomy 32 APOPTONE 32 Chronic Myeloid Leukaemia 32 modified RECIST criteria 32 unresectable 32 CYP#C# * 32 benchmark refi 32 Sergei Ignatchenko 32 mCRC patients 32 Lapatinib 32 metastatic lesions 32 operator Cesky Telecom 32 Lady Manningham Buller 32 DAS# [002] 32 interquartile range 32 cancer mCRC 32 Vugar Khalilov 32 Hodgkin lymphoma NHL 32 heavily pretreated patients 32 LEXIVA 32 haart estate 32 cytotoxic chemotherapy 32 mortgage 32 mm Stent 32 Triapine R 32 Foxtons 32 odanacatib 32 baseline LDH 32 MGTS 32 XIENCE V stent 32 Bortnikov 32 Gy 32 bone metastasis 32 SCH # 32 Viktor Zakharov 32 Peg riba 32 cabazitaxel 32 systemic bioavailability 32 iclaprim 32 anastrazole 32 chronic lymphocytic leukemia CLL 32 Uralsvyazinform 32 afatinib 32 LEUKINE 32 LDL C 32 fibrinolytic 32 Anti TNF 32 NSTE ACS 32 ErbB2 positive 32 ACE inhibitor ramipril 32 RBS NatWest 32 virologic response EVR 32 standard chemotherapy regimens 32 SETWrite 32 Votrient 32 treatment naïve genotype 32 ARs 32 +3 bp 32 placebo p 32 mg subcutaneous 32 dapagliflozin 32 methotrexate 32 LTV mortgages 32 EGFr 32 Rapid Virologic Response 32 composer Hideki Matsutake 32 pharmacodynamic 32 Ocwen Financial 32 OvaRex MAb 32 KRAS mutations 32 DAPT 32 gross NPL ratio 32 anti TNFs 32 IFN Beta 32 Cloretazine 32 KRAS mutations occur 32 Jevtana 32 ruAA + 32 relapsed 32 pioglitazone 32 Virulizin ® 32 Target Vessel Revascularization 32 mform 32 Kevin Mountford 32 Vadim Gustov 32 ToGA 32 CHOP chemotherapy 32 lumbar spine BMD 32 Nino Burjanadze 32 aciclovir 32 hormone refractory prostate cancer 32 carfilzomib 32 biologic therapy 32 nanomolar potency 32 microtubule targeting 32 CD4 + cell 32 Alexander Lebedev 32 intravesical 32 neoadjuvant treatment 32 IU mL 32 Uniastrum Bank 32 q#h 32 NNRTI resistance 32 Soviet KGB 32 BPLR 32 certolizumab 32 FOLPI 32 severe psoriasis 32 lymphocytes 32 receiving VICTRELIS 32 CVP chemotherapy 32 Muzzaker Imtiaz Shah 32 Spirita 32 mmO2 plc 32 multicentre randomized 32 Vidaza 32 PSNC